This web site is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.


Astellas Pharma, Inc.

Drug Names(s): Minodronate acid hydrate; ONO-5920; Recalbon (Japan), Bonoteo (Japan)

Description: YM529 is an oral third-generation nitrogen-containing bisphosphonate.

Partners: Ono Pharmaceutical Company, Ltd.

YM529 News

Additional information available to subscribers only:

  • Targets
  • Routes
  • Catalysts
  • Designations
  • Events

Request a Free Demo Subscriber Login Search for another drug